Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drug Pricing


Displaying 1 - 10 of 13. 10 per page. Page 1.

Advanced Search

Comparing Insulin Prices in the U.S. to Other Countries

September 23, 2020
Insulin prices have increased dramatically over the past decade in the United States. This report presents results from international price comparisons of insulins using a price index approach.

Comparison of U.S. and International Prices for Top Medicare Part B Drugs by Total Expenditures

October 24, 2018
The prices charged by drug manufacturers to wholesalers and distributors (commonly referred to as exmanufacturers prices) in the United States are 1.8 times higher than in other countries for the top drugs by total expenditures separately paid under Medicare Part B. U.S. prices were higher for most of the drugs included in the analysis, and U.S.
ASPE Data Point

Data Point: Savings Available Under Full Generic Substitution of Multiple Source Brand Drugs in Medicare Part D

July 22, 2018
ASPE analyzed Part D prescription drug event data from 2016 to estimate spending on brand drugs with generic therapeutic equivalents.

Medicare Part B Drugs: Pricing and Incentives

March 7, 2016
Medicare Part B covers infusible and injectable drugs and biologics administered in physician offices and hospital outpatient departments; as well as certain other drugs required by law provided by suppliers such as pharmacies The Part B payment method provides weak incentives for physicians to consider value – that is choose the lowest cost therapy to effectively treat a patient.
ASPE Issue Brief

Medicare Part B Reimbursement of Prescription Drugs

May 31, 2014

Health Care Cost Containment and Medical Innovation

July 22, 2012
ASPE ISSUE BRIEF Health Care Cost Containment and Medical Innovation May 2012 By: Amber Jessup, Ph.D.

A National Comparison of Prescription Drug Expenditures by Medicare Beneficiaries Living in the Community and Long-Term Care Facility Settings

February 14, 2007
This Policy Brief provides a snapshot of prescription drug use and spending in 2001, the latest year for which complete community and long-term care facility drug data are available.

Continuation of Drug Risk Adjustment

November 30, 2006
Prepared by: National Opinion Research Center (NORC) at the University of Chicago Prepared for:U.S. Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation

Understanding Variations in International Drug Prices

June 26, 2006
Rapidly rising prescription drug prices have caused many consumers, third-party payers, and policymakers to look for ways to lower their drug costs. One strategy that many have seen as a potential solution is to import drug products from countries where drug prices are lower than those in the United States — commonly called reimportation.

Impact of Policies to Limit Drug Plan's Financial Risk

October 31, 2005
This paper examines the combined effects of drug plan risk the first year of Medicare part D implementation of the combination of reinsurance, risk-adjustment and risk-corridors